Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, July 01, 2014 10:54:33 AM
bullish
$BZYR
DD Notes ~ http://www.ddnotesmaker.com/BZYR
##### recent news/filings ~ source: finance.yahoo.com
Fri, 27 Jun 2014 17:08:00 GMT ~ Burzynski Research Institute, Inc. Announces Presentations at the 16th International Symposium on Pediatric Neuro-Oncology
[PR Newswire] - HOUSTON, June 27, 2014 /PRNewswire/ -- The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 ...
read full: http://finance.yahoo.com/news/burzynski-research-institute-inc-announces-170800761.html
*********************************************************
Mon, 23 Jun 2014 20:07:00 GMT ~ Burzynski Research Institute, Inc. Announces Lifting of the FDA Partial Clinical Hold - Phase 3 Clinical Study Agreed Upon
[PR Newswire] - HOUSTON, June 23, 2014 /PRNewswire/ -- The Burzynski Research Institute, Inc. (BRI) announced today that U.S. Food and Drug Administration (FDA) has notified the company that its partial clinical hold on its IND for Antineoplastons A10/AS2-1 Injections has been lifted. The FDA has determined that under its IND the Company may initiate its planned Phase 3 study in newly diagnosed diffuse, intrinsic, brainstem glioma. The Company is continuing discussions with the Agency in an effort to finalize additional details of the phase 3 study protocol for the potential clinical trial. The FDA's decision to lift the clinical hold marks an important step in the development of Antineoplastons for the treatment of various forms of brain tumors in the US. At the same time, the Company is evaluating possible next steps for the Antineoplastons clinical program given the current progress and anticipated resource requirements of the ongoing program.
read full: http://finance.yahoo.com/news/burzynski-research-institute-inc-announces-200700646.html
*********************************************************
Thu, 05 Jun 2014 17:04:09 GMT ~ BURZYNSKI RESEARCH INSTITUTE INC Financials
read full: http://finance.yahoo.com/q/is?s=bzyr
*********************************************************
Fri, 30 May 2014 10:01:14 GMT ~ BURZYNSKI RESEARCH INSTITUTE INC Files SEC form 10-K, Annual Report
read full: http://biz.yahoo.com/e/140530/bzyr10-k.html
*********************************************************
Tue, 14 Jan 2014 21:08:13 GMT ~ BURZYNSKI RESEARCH INSTITUTE INC Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/140114/bzyr10-q.html
*********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/BZYR/company-info
Ticker: $BZYR
OTC Market Place: OTCQB
CIK code: 0000724445
Company name: Burzynski Research Institute, Inc.
Company website: http://www.burzynskiresearch.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000724445&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/BZYR/filings
Latest financials: http://www.otcmarkets.com/stock/BZYR/financials
Latest news: http://www.otcmarkets.com/stock/BZYR/news - http://finance.yahoo.com/q/h?s=BZYR+Headlines
Major holdings: http://data.cnbc.com/quotes/BZYR/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=BZYR+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/BZYR.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=BZYR
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=BZYR&search=search
DTCC: http://search2.dtcc.com/?q=Burzynski+Research+Institute%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Burzynski+Research+Institute%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Burzynski+Research+Institute%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.burzynskiresearch.com
Alexa: http://www.alexa.com/siteinfo/http://www.burzynskiresearch.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.burzynskiresearch.com
Short Sales: http://www.otcmarkets.com/stock/BZYR/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/BZYR/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/BZYR/research
Historical Prices: http://finance.yahoo.com/q/hp?s=BZYR+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=BZYR+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=BZYR+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=BZYR+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=BZYR+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=BZYR+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=BZYR
Balance Sheet: http://finance.yahoo.com/q/bs?s=BZYR
Cash Flow: http://finance.yahoo.com/q/cf?s=BZYR+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/BZYR
Bloomberg: http://www.bloomberg.com/quote/BZYR:US
Morningstar: http://quotes.morningstar.com/stock/s?t=BZYR
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=BZYR
Barchart: http://www.barchart.com/quotes/stocks/BZYR
OTC Short Report: http://otcshortreport.com/index.php?index=BZYR
Investopedia: http://www.investopedia.com/markets/stocks/BZYR/?wa=0
http://www.pennystocktweets.com/stocks/profile/BZYR
##### last known share structure ~ source: otcmarkets.com
Market Value: $56,509,686 a/o Jun 30, 2014
Shares Outstanding: 131,448,444 a/o May 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/BZYR
tnpc
Recent BZYR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:15:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/12/2023 08:15:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/13/2023 08:15:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM